Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

66108-95-0

Iohexol

66108-95-0
2276-90-6

Iothalamic acid

2276-90-6
28179-44-4

Ioxythalamic acid

28179-44-4
14885-29-1

Ipronidazole

14885-29-1
138402-11-6

Irbesartan

138402-11-6
58957-92-9

Idarubicine HCl

58957-92-9
127-51-5

Isomethyl-alpha-ionone

127-51-5
579-56-6

Isoxsuprine HCl

579-56-6
41708-76-3

Indicine N-oxide

41708-76-3
480-82-0

Indicine

480-82-0
70288-86-7

Ivermectin

70288-86-7
100286-90-6

Irinotecan HCl 3H2O

100286-90-6
54-42-2

Iodoxuridine

54-42-2
53-86-1

Indomethacin

53-86-1
256-96-2

Iminostilben

256-96-2
57469-77-9

Ibuprfen-L-Lysine (1:1) (S/S)

57469-77-9
114084-78-5

Ibandronic acid

114084-78-5
54-85-3

Isoniazid

54-85-3
113-52-0

Imipramine HCl

113-52-0
136949-58-1

Iobitridol

136949-58-1